MedCity News January 11, 2021
Anuja Vaidya

In an increasingly crowded landscape, digital health startups must figure out what sets them apart. Three startup leaders shared what differentiates their companies from the competition at this year’s J.P. Morgan Healthcare Conference.

Human tragedy is often inextricably linked with human ingenuity and innovation, a notion borne out in a myriad of ways amid the Covid-19 pandemic. As cases of the deadly virus soared, the healthcare industry responded by evolving rapidly, especially with regard to technology use. The pandemic has resulted in quick pivots to digital platforms and a proliferation of health technology startups, which then begs the question — how does a digital health company survive and thrive in this competitive landscape?

For Varsha Rao, CEO of Nurx, it...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Digital Health, Investments, Technology, Trends
A Better Connected Care Journey
Venture-backed telemental health care companies are creating a new opioid epidemic
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
The Forming of the Global Service Providers Market for Digital Health Companies
Increased Skilled Nursing Facility Spending Tied to Health Systems’ Higher Telemedicine Use

Share This Article